64 results
8-K
EX-10.1
906ahe1h 8b
30 May 18
Zafgen, Inc. Expands Executive Leadership Team with Appointment of
5:17pm
S-1
EX-10.1
2605d
18 Apr 14
IPO registration
12:00am
8-K
EX-10.3
1ysbt
12 Oct 17
Zafgen Appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to Continue as President, Appointed Chief Scientific Officer
12:00am
8-K
EX-10.1
eyevzfnitjqmsu0 yxy
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K/A
EX-10.1
pnsdub5 iq
29 Sep 20
Departure of Directors or Certain Officers
4:39pm
8-K
EX-10.1
ey7n9zgf15a57e
29 Sep 20
Departure of Directors or Certain Officers
7:06am
S-1
EX-3.3
pz6gzt24
18 Apr 14
IPO registration
12:00am
8-K
EX-10.4
q3kcctyl
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.2
4o5azdtzo6mbjc3ja8
30 May 18
Zafgen, Inc. Expands Executive Leadership Team with Appointment of
5:17pm